|

Surovatamig Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: AZD0486

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

  • AstraZeneca3

Indications

  • Cancer2
  • Large B-Cell Lymphoma (LBCL)1
  • Systemic Lupus Erythematosus1
  • Untreated Follicular Lymphoma1
  • Lupus1

Birmingham, Alabama1 trial

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site

Phase 1

Anchorage, Alaska1 trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site

Phase 3

Phoenix, Arizona1 trial

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.